Optimal timing of injection of once-daily insulin glargine in people with type 1 diabetes using insulin lispro at meal-times

被引：0
|
作者：
Ashwell, SG
Home, PD
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [21] Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
    Rosenstock, Julio
    Eliaschewitz, Freddy G.
    Heilmann, Cory R.
    Muchmore, Douglas B.
    Hayes, Risa P.
    Belin, Ruth M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S63 - S73
  • [22] Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes
    Dualib, Patricia Medici
    Dib, Sergio Atala
    Augusto, Gustavo Akerman
    Truzzi, Ana Cristina
    de Paula, Mauricio Aguiar
    Rea, Rosangela Roginski
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [23] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses
    K. M. Prasanna Kumar
    Sanjiv Shah
    Parag Shah
    Simon Cleall
    Steve Chen
    Shweta Uppal
    International Journal of Diabetes in Developing Countries, 2017, 37 : 116 - 123
  • [24] Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus
    Jeong, In-Kyung
    Chung, Choon Hee
    Zhou, Zhiguang
    Han, Jeong Hee
    Duan, Ran
    Edralin, Diana M.
    Rodriguez, Angel
    JOURNAL OF DIABETES, 2017, 9 (04) : 396 - 404
  • [25] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [26] Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
    Chantal Mathieu
    S. John Weisnagel
    Peter Stella
    Jacques Bruhwyler
    Kathy Alexandre
    Diabetes Therapy, 2020, 11 : 495 - 507
  • [27] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification-a randomized phase IV trial: Indian subpopulation analyses
    Prasanna Kumar, K. M.
    Shah, Sanjiv
    Shah, Parag
    Cleall, Simon
    Chen, Steve
    Uppal, Shweta
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (02) : 116 - 123
  • [28] Changing from once- or twice-daily basal insulin to once-daily insulin glargine using two titration regimens in Type 1 diabetes: results from the AT.LANTUS trial
    Raz, I
    Storms, F
    Rodriguez, J
    Bianchi-Biscay, M
    Davies, M
    Gomis, R
    DIABETOLOGIA, 2004, 47 : A306 - A306
  • [29] Comparison of Once-daily versus Twice-daily Injection of Insulin Detemir in Children with Type 1 Diabetes Mellitus
    Setoodeh, Aria
    Rabbani, Ali
    Sayarifard, Fatemeh
    Haghshenas, Zahra
    Sayarifard, Azadeh
    Rostami, Parastoo
    Abbasi, Farzaneh
    Bayat, Mohadeseh
    Amini, Sima
    Tavakolizadeh, Reza
    IRANIAN JOURNAL OF PEDIATRICS, 2022, 32 (06)
  • [30] Efficacy and safety of insulin glulisine and insulin lispro combined with insulin glargine in patients with Type 1 diabetes
    Prager, R
    Dreyer, M
    Robinson, A
    Busch, K
    Penfornis, A
    Souhami, E
    DIABETOLOGIA, 2004, 47 : A301 - A301
12345